Companies → Teladoc Health, Inc.
Save to list
Remove

Teladoc Health, Inc.

United States, New York, Purchase
Description
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
Address:

2 Manhattanville Rd Ste 203 Purchase

NY

10577-2118 United States

Revenue
Recent news:

Recent Stock Surges: Which Gains Are Built to Last?

Analysis of three high-performing stocks from the past month, identifying Coinbase as fundamentally strong while questioning the sustainability of gains for Teladoc Health and Krispy Kreme.

Source: IndexBox Mar 20, 2026

1 Surging Stock to Consider Right Now and 2 We Avoid

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, investors are taking notice and bidding up shares.

Source: StockStory Mar 20, 2026

Teladoc Stock Decline and Growth Concerns

Analysis of Teladoc's stock performance and business fundamentals, highlighting a major price decline, stalled growth projections, and key risks for investors.

Source: IndexBox Mar 19, 2026

3 Reasons TDOC is Risky and 1 Stock to Buy Instead

What a brutal six months it’s been for Teladoc. The stock has dropped 31.6% and now trades at $5.44, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

Source: StockStory Mar 19, 2026

Teladoc (TDOC) Suffers a Larger Drop Than the General Market: Key Insights

Teladoc (TDOC) closed at $5.42 in the latest trading session, marking a -3.39% move from the prior day.

Source: Zacks Mar 18, 2026

Online Marketplace Stocks Show Mixed Q4 Results

A review of Q4 results for online marketplace companies reveals a mixed picture, with the sector beating revenue estimates but seeing average stock prices fall post-earnings.

Source: IndexBox Mar 17, 2026

NYSE - Delayed Quote - USD
TDOC
5.35 -0.17 (-3.08%)
At close March 20 20:00 UTC
5.45 +0.10 (+1.84%)
After hours: March 20 23:55 UTC
Candle
Line
1D
5D
1M
6M
1Y
5Y
Financial Statistics
Valuation Measures
Current
Quarterly
As of 03/21/2026
Market Cap: 954.42 M
Enterprise Value: 1.21 B
Trailing P/E: N/A
Forward P/E: -6.28
PEG Ratio (5yr expected): N/A
Price/Sales (ttm): 0.37
Price/Book (mrq): 0.69
Enterprise Value/Revenue: 0.48
Enterprise Value/EBITDA: 7.56
Financial Highlights
Profitability and Income Statement
Profit Margin: -7.92%
Return on Assets (ttm): -3.20%
Return on Equity (ttm): -13.93%
Revenue (ttm): 2.53 B
Net Income Avi to Common (ttm): -200.32 M
Diluted EPS (ttm): -1.14
Balance Sheet and Cash Flow
Total Cash (mrq): 781.08 M
Total Debt/Equity (mrq): 75.06%
Levered Free Cash Flow (ttm): 226.14 M
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.